Last update 08 May 2025

Paragon Biomedical, Inc.

Private Company|1989|California, United States

Overview

Tags

Immune System Diseases
Urogenital Diseases
Antibody
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases3
Top 5 Drug TypeCount
Antibody2
Monoclonal antibody1
Top 5 TargetCount
APRIL(Tumor necrosis factor ligand superfamily member 13)1

Related

3
Drugs associated with Paragon Biomedical, Inc.
JADE-002
Target-
Mechanism-
Active Org.
Jade Biosciences, Inc. (United States) [+1]
Originator Org.
Jade Biosciences, Inc. (United States)
Active Indication
Autoimmune Diseases
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
JADE-001
Target
APRIL
Mechanism
APRIL inhibitors
Active Org.
Paragon Biomedical, Inc. [+1]
Originator Org.
Jade Biosciences, Inc. (United States)
Active Indication
Glomerulonephritis, IGA
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
JADE-003
Target-
Mechanism-
Active Org.
Jade Biosciences, Inc. (United States) [+1]
Originator Org.
Jade Biosciences, Inc. (United States)
Active Indication
Autoimmune Diseases
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
3
Clinical Trials associated with Paragon Biomedical, Inc.
NCT01291901
/ CompletedPhase 2
A Phase II, Randomized, Double Blind, Placebo-controlled, Multicenter Study to Investigate the Impact of NP2 in Subjects With Intractable Pain Due to Malignancy
NCT00710580
/ CompletedPhase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00691964
/ CompletedPhase 3
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
100 Clinical Results associated with Paragon Biomedical, Inc.
Login to view more data
0 Patents (Medical) associated with Paragon Biomedical, Inc.
Login to view more data
100 Deals associated with Paragon Biomedical, Inc.
Login to view more data
100 Translational Medicine associated with Paragon Biomedical, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 09 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
1
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
JADE-001
 ( APRIL )		Glomerulonephritis, IGA
More
Preclinical
JADE-002
-
Discovery
JADE-003
-
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free